Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 10.8 Research Service Agreement, Dated September 9, 2019, by and Between Starton Therapeutics, Inc. F/k/a Chemiocare USA Inc. and Transdermal Research Pharma Laboratories LLC
- 10.9 Assignment Agreement, Dated September 9, 2019 by and Between Starton Therapeutics, Inc. and Alpha to Omega Pharmaceutical Consultants, Inc
- 10.10 Development and Commercial License Agreement, Dated February 10, 2021, by and Between Starton Therapeutics, Inc. and Haisco Pharmaceutical Group Co., LTD
- 10.14 Executive Employment Agreement Effective As of April 27, 2023 by and Between Starton Therapeutics, Inc. and Pedro Lichtinger Waisman
- 10.15 Executive Employment Agreement Dated September 1, 2022 by and Between Starton Therapeutics, Inc. and James C. Oliver
- 10.16 Consulting Agreement Dated July 1, 2018 by and Between Starton Therapeutics, Inc. (F/k/a Chemiocare) and Atr Consultants LLC
- 23.1 Consent of Marcum LLP for Healthwell Acquisition Corp. I's Financial Statements and Notes
- 23.2 Consent of Marcum LLP for Starton Therapeutics, Inc.'s Financial Statements and Notes
- 99.7 Consent of Eric Baum to Be Named As a Director
- 99.8 Consent to Be Named As a Director
- Download Excel data file
- View Excel data file
STA similar filings
Filing view
External links